Following attachment to cell surface receptors and fusion of viral envelopes with cell membranes, retroviral core particles are deposited within the cytoplasm where viral RNA is reverse transcribed into DNA. Replication of retroviruses requires the integration of this double-stranded viral DNA into the host genome (for reviews, see references 19 and 28) . Hence, the partitioning of this subviral preintegration complex among subcellular compartments represents a critical event in the retroviral life cycle. The manner in which this process occurs may vary among the different retroviruses.
Human immunodeficiency virus type 1 (HIV-1), a lentivirus capable of infecting nondividing cells (34) , possesses determinants reported to promote the active transport of the viral preintegration complex through the nucleopore (7). In contrast, active transport cannot be detected with Moloney murine leukemia virus (MMLV) which can infect only dividing cells (39) . It has been proposed that disassembly of the nuclear envelope at mitosis removes a subcellular barrier to permit access of the MMLV preintegration complex to chromosomal DNA (33, 39) .
HIV-1 nuclear transport functions have been ascribed to two specific determinants: (i) a nuclear localization signal (NLS) in the N terminus of the viral matrix protein (MA) that resembles the simian virus 40 (SV40) large-T-antigen NLS (6, 44) and (ii) an undetermined region of the viral Vpr protein (22) . MA has multiple roles during the viral life cycle, and it has been proposed that the karyophilic properties of MA are modulated through phosphorylation of tyrosine (18) or serine-threonine residues (for a recent review, see reference 42).
Avian sarcoma virus (ASV), like MMLV, requires dividing cells to establish a productive infection (23, 25, 43) . However, this requirement may reflect a limitation in proviral gene expression, as viral DNA can be synthesized and integrated during S phase and prior to disassembly of the nuclear envelope (24) . How the ASV preintegration complex traverses the nuclear envelope is unknown. The viral integrase (IN) is an integral component of the preintegration complex of ASV and other retroviruses (5, 16, 32) . When expressed independently in eukaryotic cells, either transiently (36) or in a stable cell line (37) , ASV IN localizes in the nucleus. In this study, we transiently expressed various IN-␤-galactosidase fusions in an established assay (27) and have identified an NLS that appears to be unique to the ASV IN.
ASV IN has an NLS. To functionally identify the NLS(s) of ASV IN (in our Schmidt-Ruppin B strain), we first constructed plasmids pIN253␤gal, pIN206␤gal, and pIN63␤gal (Fig. 1C, D , and E, respectively) which encode C-terminally truncated derivatives of IN (produced by Bal 31 deletion mutagenesis) fused to the eighth codon of the lacZ gene (10) . These and subsequent ASV IN expression plasmids were derivatives of pBC12-p32 (36) , an ASV IN eukaryotic expression vector containing the ASV long terminal repeat (LTR) promoter and SV40 ori and polyadenylation signals. Other ASV IN-␤-galactosidase fusion plasmids were constructed by in-frame replacement of the IN sequences in pIN253␤gal with PCR-generated products that included portions of ASV IN, using conveniently located BglII and BamHI restriction sites. The fusion proteins expressed by these plasmids contain the indicated amino acids of IN fused to ␤-galactosidase ( Fig. 1F and G) . Forty-eight to 72 h following DEAE-dextran transfection of COS-1 cells that were cultured on poly-D-lysine-coated coverslips, the cells were washed with phosphate-buffered saline and fixed with a 4% solution of paraformaldehyde. IN-␤-galactosidase fusions were localized by indirect immunofluorescence using an anti-␤-galactosidase murine monoclonal antibody (Promega). Bound antibody was detected with biotinylated antimouse immunoglobulin (Vector Labs) and avidin-conjugated Texas Red (Vector Labs). Nuclei were counterstained with 4Ј,6Ј-diamidino-2-phenylindole (DAPI). Indirect immunofluorescence of Texas Red-stained cells was visualized with a laser confocal microscope (Bio-Rad), and the confocal sections were rendered on an SGI workstation using the program Voxel View. The results (Fig. 1C) showed that ␤-galactosidase fused with the first 253 amino acids of ASV IN was located exclusively in the nucleus in a manner similar to that observed with the SV40 large-T-antigen fusion protein expressed from plasmid pL7RH␤gal (27) that was included as a positive control (Fig. 1B) . In contrast, ␤-galactosidase fused with the first 206 amino acids (or less) of ASV IN or with no fusion, as expressed from the lacZ gene in plasmid pCH110 (Pharmacia), was found exclusively in the cytoplasm (Fig. 1D , E, and A, respectively). Results with the pIN188-253␤gal construct (Fig. 1F ) indicated that the karyophilic determinant of ASV IN is located within this internal region of the protein and that it can function independently of the remainder of the protein to drive cytoplasm-localized ␤-galactosidase into the nucleus.
A putative ASV IN NLS that spans residues 261 to 266 and thus falls outside of the region from residues 188 to 253 was noted by Mumm et al. (37) . To determine whether a second functional NLS exists in the extreme C terminus of the ASV IN, we constructed a lacZ fusion that includes codons 253 to 286. Immunostaining of COS-1 cells that express the pIN253-286␤gal construct showed this fusion protein to be predominantly cytoplasmic (Fig. 1G) . Thus, there appears to be only one functional NLS in ASV IN. However, we cannot exclude the possibility that the segment from residues 261 to 266 contains a second, weak karyophilic signal that is undetected in our assay. The results obtained with all of the constructs shown in Fig. 1 were confirmed by direct cytochemical staining for subcellular location by using the 5-bromo-4-chloro-3-indolyl-␤-D-galactoside (X-Gal) indicator substrate (data not included). In addition, each of the fusion proteins exhibited the expected electrophoretic mobilities, examined after immunoprecipitation (with an anti-␤-galactosidase antibody) from extracts of [ 35 S]methionine-labeled transfected COS-1 cells (data not shown).
HIV-1 IN-␤-galactosidase fusions localize to the cytoplasm. The segment of ASV IN comprising residues 188 to 253 does not contain a stretch of basic residues that resembles the known mono-or bipartite NLS motifs (27, 38 ; reviewed in reference 4). Furthermore, unlike the amino-terminal zinc finger motif and the central D,D(35)E motif (29, 31) which are highly conserved among all retroviral INs, no conserved sequence motif has been identified in their carboxyl-terminal regions. Despite this lack of sequence conservation, we considered the possibility that some conserved structural element might be revealed by examining the karyophilic properties of HIV-1 IN. Accordingly, a series of HIV-1 IN-lacZ fusions were constructed in the pLdK3pA vector (a derivative of pL3 [17] ) and expressed under the control of the HIV-1 LTR. Because we previously observed that HIV-1 IN expression is Rev dependent (11), a Rev-responsive element was introduced along with the lacZ gene upstream of the polyadenylation signal to produce pLdK3lacZ-RREpA. Unexpectedly, we found that expression of the HIV-1 IN-␤-galactosidase fusion proteins did not require cotransfection with a Rev-expressing plasmid (Fig. 2) . The constructs described here are intronless, and this feature may alleviate the Rev requirement for efficient expression (21) . The pLdk3lacZ-RREpA plasmid contains unique HindIII and BamHI sites between the HIV-1 LTR promoter and the lacZ gene. HIV IN-lacZ fusions were constructed by PCR amplification of sequences from the HIV-1 (Bru isolate) IN expression clone pCG6 (11) using (i) a 5Ј primer containing a HindIII site, translational initiation signals, and an ATG start codon followed by sequences corresponding to the 5Ј end of the HIV-1 gene; and (ii) a 3Ј primer containing specific sequences homologous to the distinct segments of HIV-1 IN and a BamHI site that would permit in-frame fusion with a compatible site within the lacZ gene. Each of the constructs was introduced into HLtat cells (40) by the calcium phosphate precipitation method (20) . Direct cytochemical staining with X-Gal or immunostaining with a monoclonal anti-␤-galactosidase primary antibody revealed that all of the fusion proteins localized to the cytoplasm. Results from the latter experiment are depicted in Fig. 2 . Similar results were obtained upon transfection of COS-1 cells with the HIV-1 IN-␤-galactosidase fusion constructs and a tat-expressing plasmid. We also confirmed that these fusions included an HIV-1 IN segment by repeating the indirect immunofluorescence in the transfected HL-tat cells using anti-HIV-1 IN monoclonal antibodies that recognize an epitope in the N terminus (3). As with the anti-␤-galactosidase monoclonal antibody, fluorescence was restricted to the cytoplasm (not shown).
The localization of HIV-1 IN fusions to the cytoplasm contrasts with our earlier observations that independently expressed HIV-1 IN localizes to the nucleus in transfected COS-1 cells (26) . It is possible that HIV-1 IN contains a weak NLS that is not detectable in this specific functional assay. Alternatively, at 32 kDa, independently expressed monomeric IN is well below the molecular weight cutoff for passive diffusion of molecules across the nuclear pore. Hence, monomeric IN may diffuse passively and be retained in the nucleus through its C-terminal DNA-binding domain (15, 35) . The significantly larger IN-␤-galactosidase fusions are effectively excluded from the nucleus. Thus, the discrepancy between our previous observations and the results shown in Fig. 2 may be attributable to the differences in the sizes of the proteins that were examined in the two studies. A similar discrepancy has been reported for the HIV-1 Vpr protein. When expressed independently, this 11-kDa protein localizes to the nucleus, yet Vpr-␤-galactosidase fusions are effectively excluded from the nucleus (12) . HIV-1 infects nondividing cells, thus the preintegration complex must traverse the nuclear envelope for integration to occur. Nuclear localization of the HIV-1 preintegration complex in such cells is reported to be facilitated, in a redundant fashion, by the MA and Vpr HIV proteins (22, 42) . Our experiments failed to reveal karyophilic determinants in HIV-1 IN. However, the existence of a weak NLS or an indirect role for this protein in nuclear localization cannot be excluded. 
Mapping the ASV IN NLS.
To further characterize the karyophilic property of ASV IN, a PCR-based approach was used to construct a series of ASV IN-lacZ fusions that progressively reduced the ASV IN component (Fig. 3) . Plasmid pIN195-242␤gal expressed a fusion protein that was predominantly located in the nucleus. Moreover, immunostaining revealed a homogeneous distribution throughout the nucleoplasm and exclusion from the nucleolus (Fig. 3A) . Additional N-terminal truncation, to residue 206, did not change the subcellular distribution of the fusion protein (Fig. 3G) . However, removal of two more N-terminal amino acids, to residue 208, abolished nuclear localization (Fig. 3C) . Thus, it appears that the N-terminal boundary of the ASV IN NLS is either K206 or T207. As the IN208-242␤gal product localized to the cytoplasm (Fig. 3C) , the karyophilic properties of the IN195-242␤-gal fusion can not be attributed to an artificial region that spans the junction between IN residue 242 and the adjoining residues of ␤-galactosidase.
The C-terminal boundary of the ASV IN NLS is less certain. Plasmids pIN201-235␤gal and pIN206-235␤gal expressed products with strong karyophilic properties ( Fig. 3F and G) , whereas a plasmid with IN sequences that end at codon 232, such as pIN201-232␤gal, expressed a fusion protein that displayed both nuclear and cytoplasmic staining (Fig. 3H) . Because the three residues downstream of E232 appear to be required for distinct partitioning, we place the C-terminal boundary of the NLS at or near K235.
There is no conserved amino acid motif among the different INs in the segment that includes the ASV IN NLS. Sequence alignments suggest that it may include part of a hinge region between distinct structural elements in the catalytic core and C-terminal domains (1, 2) . However, the amino acid sequences differ significantly in this region of the lenti-and nonlentiviruses. Residue 186 of HIV-1 IN marks the beginning of a stretch of basic amino acids, termed the L region (9) , that are found only among the lentiviral integrases. In the crystal structure of the HIV-1 IN core domain, these L-region sequences are included in a structural turn between alpha helices (alpha helices 5 and 6) that are integral elements of the dimer interface (14) . This turn is not seen in the ASV IN core structure which terminates with an alpha helix analogous to alpha helix 5 of HIV-1 IN (8) . Assuming that the transiently expressed fusion protein is folded properly, under our assay conditions the basic L region of HIV-1 IN does not function as an NLS.
The functional NLS that we have mapped in ASV IN does contain basic residues, but not in the short tandem arrays that characterize known nuclear transport signals (4, 13, 41) . Inspection of the sequence also shows a rather high percentage of prolines (six prolines within a 16-amino-acid stretch). The basic residues cluster toward the ends of the segment and are separated by 10 amino acids in the center. This separation bears some resemblance to the bipartite NLSs identified in other proteins (38) . However, unlike known mono-or bipartite signals, none of the basic amino acids are adjacent in the ASV IN NLS. A proline-rich region is conserved among the nonlentiviruses in an analogous location (9) . The significance of this feature remains to be determined. Recent site-directed mutagenesis studies (30) have shown that the introduction of single, nonconservative substitutions for proline 215 or for each of three basic amino acids in the ASV IN NLS significantly decrease its karyophilic activity and also cause a delay in viral replication. Studies that aim to identify the specific cellular factor that recognizes the ASV IN NLS are currently under way. The results should provide important insight into the nuclear transport of retroviral preintegration complexes.
